ComplianceOnline

Potential Endocrine Disrupters Screened in EPA List of Chemicals

  • Date: November 28, 2010
  • Source: Admin
Access Regulatory Compliance Training sessions led by expert panelists below.

Compliance Webinars | Virtual Seminars for Professionals

 

134 chemical were identified by the U.S. Environmental Protection Agency (EPA) for screening. The purpose is to identify possible disruptive effects on the endocrine system. Chemicals that may interference with the body’s endocrine system, disrupting its development, reproduction, neurology, and immunity are called endocrine disruptors. The safety of the identified chemicals is crucial, and the next step in the EPA process.
 
“Endocrine disruptors represent a serious health concern for the American people, especially children. Americans today are exposed to more chemicals in our products, our environment and our bodies than ever before, and it is essential that EPA takes every step to gather information and prevent risks,” said EPA Administrator Lisa P. Jackson. “We are using the best available science to examine a larger list of chemicals and ensure that they are not contaminating the water we drink and exposing adults and children to potential harm.”
 
Several of the chemicals thus identified could be found in drinking water sources, posing a serious threat to a large number of people exposed to it. The Safe Drinking Water Act (SDWA) lists several of the chemicals in the EPA list as priorities. Moreover, the EPA’s registration review program is evaluating many of the chemicals in the list that have pesticide active ingredients, in order to ensure that they comply with the current scientific and regulatory standards. The review program will help pave the way forward, identifying the need, if any, for further tests or steps to deal with the endocrine disrupting chemicals.
 
Gasoline, personal care pesticides, plastics, products, solvents, and pharmaceuticals, including benzene, ethylene glycol, erythromycin, perchlorate, and urethane are some of the products that contain the identified chemicals.
 
The Endocrine Disruption Screening Program (EDSP) is authorized to use validated methods to screen and test chemicals to identify potential endocrine disruptors, determine adverse effects, dose-response, assess risk, and manage risk under current laws.
 
The document ‘Draft Policies and Procedures for Screening Safe Drinking Water Act Chemicals’ available at http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480b953c1&disposition=attachment&contentType=html, was drafted to explain the policies and procedures relevant to the Endocrine Disruption Screening Program EDSP SDWA chemicals.
 
Source
http://yosemite.epa.gov/opa/admpress.nsf/d0cf6618525a9efb85257359003fb69d/5f77e9903c4e2e48852577dd005bc7ce!OpenDocument
http://www.epa.gov/endo/pubs/regaspects/index.htm
 

 

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
On Demand Access Anytime
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading